These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3096128)

  • 1. Electrophysiologic testing of tocainide and mexiletine for ventricular tachycardia: assessment of the need to test both drugs.
    Miller SM; Martinez JJ; Deal BJ; Bauman JL; Scagliotti D; Hariman RJ; Gallastegui JL
    Am Heart J; 1986 Nov; 112(5):1114-6. PubMed ID: 3096128
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mexiletine and tocainide: does response to one predict response to the other?
    Hession M; Blum R; Podrid PJ; Lampert S; Stein J; Lown B
    J Am Coll Cardiol; 1986 Feb; 7(2):338-43. PubMed ID: 3080508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.
    Murray KT; Barbey JT; Kopelman HA; Siddoway LA; Echt DS; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1989 May; 45(5):553-61. PubMed ID: 2498025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
    Hellestrand KJ
    Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
    Wagner WL; Manz M; Lüderitz B
    Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class 1B agents lidocaine, mexiletine, tocainide, phenytoin.
    Rizzon P; Di Biase M; Favale S; Visani L
    Eur Heart J; 1987 Mar; 8 Suppl A():21-5. PubMed ID: 3107988
    [No Abstract]   [Full Text] [Related]  

  • 9. Mexiletine and tocainide: a profile of two lidocaine analogs.
    Woosley RL
    Ration Drug Ther; 1987 Mar; 21(3):1-7. PubMed ID: 3116601
    [No Abstract]   [Full Text] [Related]  

  • 10. Tocainide and mexiletine. Orally effective lidocaine analogues.
    Roden DM
    Arch Intern Med; 1985 Mar; 145(3):417-8. PubMed ID: 3919665
    [No Abstract]   [Full Text] [Related]  

  • 11. Tocainide--an alternative to mexiletine.
    Drug Ther Bull; 1982 Jul; 20(14):55-6. PubMed ID: 6814882
    [No Abstract]   [Full Text] [Related]  

  • 12. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mexiletine in lidocaine-resistant ventricular tachycardia.
    Abinader EG
    Am Heart J; 1984 Apr; 107(4):808-9. PubMed ID: 6702581
    [No Abstract]   [Full Text] [Related]  

  • 14. Exacerbation of ventricular tachycardia by tocainide.
    Cheesman M; Ward DE
    Clin Cardiol; 1985 Jan; 8(1):47-50. PubMed ID: 3917881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmia agents (II): Mexiletine, aprindine, tocainide and amiodarone].
    Kobayashi K; Itoh S; Fukuzaki H
    Nihon Rinsho; 1985 Nov; 43(11):2428-34. PubMed ID: 3936949
    [No Abstract]   [Full Text] [Related]  

  • 16. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term therapy with tocainide for malignant ventricular tachyarrhythmias.
    Hohnloser SH; Lange HW; Raeder EA; Podrid PJ; Lown B
    Circulation; 1986 Jan; 73(1):143-9. PubMed ID: 3079677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mexiletine in the treatment of lidocaine-resistant ventricular tachycardia. Preliminary results].
    Santinelli V; Chiariello M; Stanislao M; Turco P; Clarizia M; Condorelli M
    G Ital Cardiol; 1982; 12(6):457-9. PubMed ID: 7160572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible proarrhythmic effects of tocainide in dilated cardiomyopathy.
    Brownstein SL; Constantin L; Kienzle MG; Martins JB
    Pacing Clin Electrophysiol; 1988 Jul; 11(7):1032-5. PubMed ID: 2457881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.
    Pratt CM; Luck JC; Mann DE; Wyndham CR
    Cardiol Clin; 1984 Feb; 2(1):35-46. PubMed ID: 6443563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.